Display Settings:

Format

Send to:

Choose Destination
    Mycoses. 2008 Sep;51 Suppl 2:25-45.

    Invasive candidiasis in the ICU: evidence based and on the edge of evidence.

    Source

    Interdisciplinary Intensive Care Unit, Department of Medicine, University of Leipzig, Leipzig, Germany. eike.hollenbach@medizin.uni-leipzig.de

    Abstract

    Invasive candidiasis is a common nosocomial infection among critically ill patients, constitutes an important cause of sepsis, and is associated with significant morbidity and mortality. The Infectious Diseases Society of America (IDSA) has created evidence-based guidelines for the management of invasive candidiasis. However, several new antifungal agents with excellent activity against Candida spp. and favourable safety profiles have been introduced successfully in the clinical setting since the IDSA guidelines were published in late 2003. Further, the role of antifungals is not entirely clear in the intensive care unit (ICU) setting. Therefore, this article discusses daily problems in the prophylaxis and treatment of invasive candidasis in interdisciplinary ICUs.

    PMID:
    18721330
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk